Vistagen Therapeutics, Inc. (VTGN): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2024-03-31, while the company's latest annual report covers the year ended 2026-03-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$25.81M
Year ended 2024-03-31
2022-03-31: -$45.26M2023-03-31: -$50.24M2024-03-31: -$25.81M-$25.81M
2022-03-31 Free Cash Flow (USD) 2024-03-31
Period endedFree Cash FlowChange YoYSource filing
2024-03-31-$25.81Mn/m2025-06-17, From 2023-04-01
2023-03-31-$50.24Mn/m2024-06-11, From 2022-04-01
2022-03-31-$45.26Mn/a2023-06-28, From 2021-04-01